NovoCure Ltd — Director's Dealing 2025

Nov 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2025-10-31

Reporting Person: Puri Michal Nath (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-31	Ordinary Shares	F	752.00	$12.82	Disposed	163762.00	Direct

Footnotes

F1: Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).